TNFSF10 and cancer: Cancer cells in the TDLN escape NK-cell mediated immune response by expressing MHC class I like analogues, secreting soluble ligands that can bind to NK cell receptors or by reducing the expression of effector ligands such as TRAIL on NK cells [186].